0,805  0,002  SULT1A3 substrate
0,800  0,005  GST A substrate
0,781  0,005  Aldehyde oxidase inhibitor
0,788  0,013  Caspase 9 stimulant
0,773  0,005  Cardiovascular analeptic
0,771  0,004  CTGF expression inhibitor
0,669  0,009  5 Hydroxytryptamine release stimulant
0,665  0,005  Antimutagenic
0,667  0,008  UGT1A9 substrate
0,660  0,004  Peroxidase inhibitor
0,655  0,006  UGT1A6 substrate
0,652  0,006  5 Hydroxytryptamine release inhibitor
0,630  0,005  Skin whitener
0,622  0,003  Tyrosine 3 hydroxylase inhibitor
0,608  0,007  GABA C receptor rho-3 antagonist
0,605  0,007  Superoxide dismutase inhibitor
0,598  0,006  Calcium channel L-type activator
0,583  0,009  Free radical scavenger
0,571  0,009  FMO1 substrate
0,589  0,027  TNF expression inhibitor
0,563  0,005  Sulfotransferase substrate
0,571  0,013  Antioxidant
0,550  0,009  UDP-glucuronosyltransferase substrate
0,544  0,004  Pneumotoxic
0,550  0,014  Ulceration
0,545  0,014  NOS2 expression inhibitor
0,536  0,006  UGT2B4 substrate
0,541  0,015  NOS3 expression inhibitor
0,543  0,018  Histamine release inhibitor
0,535  0,016  AR expression inhibitor
0,531  0,019  12-Lipoxygenase inhibitor
0,514  0,004  FMO3 substrate
0,509  0,004  5 Hydroxytryptamine uptake stimulant
0,518  0,021  Sensitization
0,503  0,007  Genotoxic
0,501  0,007  Antiseptic
0,498  0,004  GST M1-1 substrate
0,496  0,004  Cystathionine beta-synthase inhibitor
0,504  0,023  CYP1A2 substrate
0,509  0,031  Cholesterol antagonist
0,505  0,032  Antipruritic, allergic
0,510  0,038  15-Lipoxygenase inhibitor
0,477  0,008  Flavin-containing monooxygenase substrate
0,512  0,043  Transcription factor NF kappa B inhibitor
0,495  0,026  Antihypercholesterolemic
0,492  0,023  Cardioprotectant
0,494  0,026  CYP2D6 substrate
0,481  0,016  Amyloid beta aggregation inhibitor
0,476  0,014  Antihypertriglyceridemic
0,490  0,029  Bone diseases treatment
0,458  0,002  SULT1A1 substrate
0,485  0,031  Respiratory analeptic
0,475  0,024  Antiosteoporotic
0,458  0,009  Monophenol monooxygenase inhibitor
0,479  0,030  CYP2C19 substrate
0,462  0,018  Cardiodepressant
0,451  0,009  UGT1A3 substrate
0,510  0,071  Apoptosis agonist
0,440  0,005  Neurotrophic factor enhancer
0,447  0,012  Calcium channel activator
0,440  0,005  UGT2B1 substrate
0,474  0,041  CYP2C9 substrate
0,433  0,006  UGT2B15 substrate
0,440  0,014  UGT1A1 substrate
0,438  0,012  Anesthetic general
0,427  0,004  Estrogen receptor beta antagonist
0,452  0,029  Caspase 3 stimulant
0,434  0,012  UGT1A4 substrate
0,441  0,026  ICAM1 expression inhibitor
0,415  0,004  Estrogen antagonist
0,439  0,029  Chemoprotective
0,446  0,042  Vasodilator, peripheral
0,432  0,030  Lipoxygenase inhibitor
0,404  0,008  GST P1-1 substrate
0,396  0,002  SULT1A2 substrate
0,398  0,004  Carbonic anhydrase III inhibitor
0,417  0,025  Hypoglycemic
0,396  0,004  Histidine decarboxylase inhibitor
0,422  0,033  Analeptic
0,419  0,035  Radioprotector
0,409  0,026  Antipyretic
0,395  0,012  Melanin inhibitor
0,384  0,005  Interleukin 4 antagonist
0,381  0,003  Phenylalanine 4-hydroxylase inhibitor
0,384  0,010  Alpha-N-acetylglucosaminidase inhibitor
0,428  0,055  CYP3A4 substrate
0,377  0,005  Carcinogenic, group 1
0,400  0,029  Proliferative diseases treatment
0,384  0,013  Antihypotensive
0,375  0,006  GABA C receptor agonist
0,373  0,004  Carbonic anhydrase XV inhibitor
0,399  0,030  Hypoxia-inducible factor 1 alpha inhibitor
0,419  0,053  CYP2C19 inhibitor
0,384  0,018  P-glycoprotein inhibitor
0,384  0,019  Abortion inducer
0,365  0,004  Alcohol oxidase inhibitor
0,364  0,003  Creatine kinase inhibitor
0,368  0,011  Amylase inhibitor
0,356  0,005  Nitric-oxide synthase stimulant
0,364  0,013  VCAM1 expression inhibitor
0,372  0,021  RNA-directed DNA polymerase inhibitor
0,374  0,026  Pyruvate kinase inhibitor
0,376  0,031  Chemopreventive
0,422  0,079  Cyclophilin D inhibitor
0,422  0,079  Antidiabetic
0,399  0,058  CYP2C9 inhibitor
0,370  0,029  Antineoplastic (osteosarcoma)
0,352  0,012  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,369  0,029  Sodium/bile acid cotransporter inhibitor
0,343  0,005  Estrogen agonist
0,371  0,033  Antihypoxic
0,351  0,013  Lipid peroxidase inhibitor
0,380  0,042  Vasodilator, coronary
0,345  0,009  Toxic, respiratory center
0,371  0,035  Interleukin antagonist
0,332  0,010  Glutathione S-transferase substrate
0,324  0,002  DOPA decarboxylase inhibitor
0,345  0,024  Growth hormone agonist
0,334  0,013  NOS3 expression enhancer
0,351  0,034  Insulysin inhibitor
0,361  0,049  Spasmolytic
0,369  0,058  Antithrombotic
0,326  0,016  Acaricide
0,340  0,032  Interleukin agonist
0,310  0,003  Glutamate decarboxylase inhibitor
0,357  0,053  Apoptosis antagonist
0,321  0,017  Interferon gamma antagonist
0,312  0,009  5-Lipoxygenase inhibitor
0,327  0,026  Eye irritation, high
0,343  0,043  Cytostatic
0,302  0,004  Macrophage migration inhibitory factor inhibitor
0,330  0,035  Nitric oxide antagonist
0,298  0,004  Estrogen receptor beta agonist
0,305  0,012  M18 aspartyl aminopeptidase inhibitor
0,316  0,023  UGT2B7 substrate
0,308  0,020  Carcinogenic, group 3
0,305  0,017  CYP2B6 inhibitor
0,330  0,045  Radiosensitizer
0,290  0,006  UGT2B10 substrate
0,292  0,008  Excitatory amino acid transporter EAAC1 inhibitor
0,288  0,006  Carbonic anhydrase XIII inhibitor
0,294  0,012  Antihyperlipoproteinemic
0,287  0,007  Carbonic anhydrase VI inhibitor
0,336  0,057  Lipoprotein disorders treatment
0,282  0,004  Estrogen receptor alpha agonist
0,282  0,006  Porphobilinogen synthase inhibitor
0,289  0,013  Succinate dehydrogenase inhibitor
0,295  0,019  Antihelmintic (Nematodes)
0,367  0,091  Antineoplastic (breast cancer)
0,302  0,028  5 Hydroxytryptamine 1E antagonist
0,286  0,012  UGT2B9 substrate
0,278  0,006  VEGF expression inhibitor
0,279  0,008  Farnesoid X receptor antagonist
0,322  0,055  Antineoplastic (small cell lung cancer)
0,273  0,008  Antispirochetal
0,274  0,013  Antifungal enhancer
0,321  0,060  Interleukin 2 agonist
0,283  0,025  Antipruritic, non-allergic
0,316  0,060  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,271  0,015  Aldehyde dehydrogenase inhibitor
0,279  0,026  Antianorexic
0,266  0,012  UDP-glucose 4-epimerase inhibitor
0,272  0,018  Antiviral (West Nile virus)
0,263  0,009  GABA C receptor rho-2 antagonist
0,274  0,021  Phospholipase C inhibitor
0,376  0,125  Alpha-glucosidase inhibitor
0,261  0,009  Catenin beta inhibitor
0,287  0,038  Antiviral (HIV)
0,255  0,007  Coagulant
0,252  0,004  SULT1E1 substrate
0,302  0,054  Transcription factor STAT inhibitor
0,339  0,092  Calpain 2 inhibitor
0,287  0,040  Antiparkinsonian, rigidity relieving
0,252  0,005  HIV-1 integrase (Overall Integration) inhibitor
0,252  0,005  Gastritis treatment
0,297  0,053  Antiamyloidogenic
0,290  0,045  Psychostimulant
0,287  0,043  Gastrin inhibitor
0,251  0,006  CF transmembrane conductance regulator agonist
0,249  0,005  Keratolytic
0,266  0,023  Protein kinase stimulant
0,260  0,017  Aldehyde oxidase substrate
0,246  0,004  Prolactin inhibitor
0,288  0,047  Cyclic AMP phosphodiesterase inhibitor
0,307  0,067  Antineoplastic (endocrine cancer)
0,317  0,078  Prostate cancer treatment
0,286  0,048  Carcinogenic
0,250  0,013  Antihemorrhagic
0,294  0,057  Transcription factor STAT3 inhibitor
0,273  0,037  DNA methyltransferase I inhibitor
0,367  0,132  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,324  0,090  Stroke treatment
0,287  0,054  Antiglaucomic
0,250  0,017  Hexokinase inhibitor
0,279  0,047  Mutagenic
0,286  0,054  Angiogenesis stimulant
0,249  0,018  Cholesterol synthesis inhibitor
0,251  0,021  LDLR expression enhancer
0,260  0,029  Insulin sensitizer
0,293  0,063  Teratogen
0,284  0,054  Cytotoxic
0,266  0,040  DNA methylase inhibitor
0,247  0,021  NADPH oxidase inhibitor
0,240  0,015  Ferrochelatase inhibitor
0,287  0,062  Embryotoxic
0,231  0,007  Antihelmintic (Fasciola)
0,231  0,007  Antihelmintic (Trematoda)
0,235  0,012  Antirickettsial
0,228  0,005  Interleukin 12 antagonist
0,253  0,030  Protein-tyrosine phosphatase inhibitor
0,276  0,053  DNA synthesis inhibitor
0,237  0,015  Carcinogenic, group 2B
0,376  0,154  Antiinflammatory
0,230  0,008  GABA C receptor antagonist
0,227  0,006  Adenylate cyclase stimulant
0,227  0,007  Estrogen receptor alpha antagonist
0,231  0,011  Cyclooxygenase 3 inhibitor
0,332  0,113  Antibacterial
0,285  0,065  CYP1A2 inhibitor
0,243  0,025  Phospholipase A2 inhibitor
0,225  0,007  Chronic obstructive bronchitis treatment
0,237  0,020  Antiprotozoal (Coccidial)
0,289  0,074  Antineoplastic (melanoma)
0,234  0,021  Uterine stimulant
0,227  0,014  Toll-Like receptor 2 antagonist
0,293  0,080  Immunostimulant
0,268  0,056  Antineoplastic (sarcoma)
0,231  0,019  Chelator
0,236  0,024  Neurotensin receptor agonist
0,248  0,038  Dual specificity phosphatase inhibitor
0,223  0,015  Arachidonic acid antagonist
0,247  0,041  Dual specificity phosphatase 3 inhibitor
0,270  0,064  Antiprotozoal (Leishmania)
0,219  0,013  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,233  0,028  Tubulin antagonist
0,235  0,031  MAO inhibitor
0,264  0,061  Hypolipemic
0,206  0,005  Antidote, mercury
0,229  0,029  Antidote
0,226  0,025  Insulin secretagoues
0,234  0,033  Hair growth stimulant
0,247  0,047  Antialcoholic
0,208  0,009  TRPA1 agonist
0,201  0,002  Dopamine D5 agonist
0,221  0,022  DNA polymerase I inhibitor
0,207  0,009  Sphingosine 1-phosphate receptor 5 antagonist
0,214  0,017  Xanthine oxidase inhibitor
0,240  0,043  Muscle relaxant
0,307  0,110  Immunosuppressant
0,199  0,003  Vesicle monoamine transporter inhibitor
0,264  0,069  Tumour necrosis factor alpha release inhibitor
0,207  0,012  Alcohol dehydrogenase inhibitor
0,199  0,004  UGT2B11 substrate
0,199  0,005  Carbonic anhydrase VB inhibitor
0,254  0,061  Calpain inhibitor
0,225  0,031  Skin irritative effect
0,229  0,037  Histone acetyltransferase inhibitor
0,200  0,008  GABA C receptor rho-1 antagonist
0,198  0,008  Sphingosine 1-phosphate receptor 2 antagonist
0,201  0,013  Photosensitizer
0,219  0,030  Heat shock protein 90 antagonist
0,213  0,025  Protein-tyrosine phosphatase 1B inhibitor
0,254  0,067  Vasodilator
0,189  0,003  Estrogen-related receptor beta agonist
0,190  0,004  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,221  0,035  Skeletal muscle relaxant
0,248  0,062  Antiparasitic
0,221  0,036  Antiparkinsonian, tremor relieving
0,211  0,027  MAO A inhibitor
0,277  0,093  CYP3A4 inhibitor
0,188  0,005  Antifungal (Pneumocystis)
0,196  0,013  Vanilloid 1 agonist
0,278  0,096  Antineoplastic (brain cancer)
0,190  0,008  Carbonic anhydrase V inhibitor
0,192  0,011  Sphingomyelinase inhibitor
0,232  0,052  Antihelmintic
0,186  0,007  Alpha tubulin antagonist
0,218  0,039  5 Hydroxytryptamine 3E antagonist
0,197  0,018  Choleretic
0,229  0,050  Hepatoprotectant
0,194  0,015  NAT2 substrate
0,191  0,012  Triose-phosphate isomerase inhibitor
0,209  0,032  Antidiarrheal
0,217  0,040  Heat shock protein 90 alpha antagonist
0,220  0,043  Tumour necrosis factor antagonist
0,205  0,028  Mannose-6-phosphate isomerase inhibitor
0,227  0,053  Non-steroidal antiinflammatory agent
0,184  0,011  NAD(P)H dehydrogenase (quinone) inhibitor
0,180  0,008  GST T1-1 substrate
0,199  0,028  Neurotrophic factor
0,218  0,047  Mcl-1 antagonist
0,181  0,011  Heat shock protein 70 antagonist
0,183  0,012  Actinic keratosis treatment
0,204  0,034  ATPase inhibitor
0,256  0,086  Antidiabetic (type 2)
0,186  0,017  Mucolytic
0,280  0,112  Antileukemic
0,176  0,009  Ca2+-transporting ATPase inhibitor
0,191  0,024  Aminopeptidase B inhibitor
0,202  0,035  Bone formation stimulant
0,195  0,030  Psychosexual dysfunction treatment
0,171  0,007  Carbonic anhydrase VA inhibitor
0,241  0,078  Antineoplastic (glioma)
0,189  0,026  MAO B inhibitor
0,168  0,005  Purinergic P2X1 antagonist
0,202  0,040  Interleukin 6 antagonist
0,171  0,010  Adrenaline agonist
0,166  0,005  GABA aminotransferase inhibitor
0,163  0,003  Sphingosine kinase 2 inhibitor
0,175  0,016  Arylamine N-Acetyltransferase substrate
0,187  0,029  Antitussive
0,181  0,022  Bronchodilator
0,169  0,012  HIV-1 integrase (3'-Processing) inhibitor
0,207  0,050  Antiviral (Ebola)
0,167  0,011  Anabolic
0,192  0,036  Alkaline phosphatase inhibitor
0,174  0,019  Opioid antagonist
0,270  0,117  Prostaglandin dehydrogenase inhibitor
0,167  0,014  NADH dehydrogenase inhibitor
0,168  0,015  Phosphofructokinase-1 inhibitor
0,155  0,002  SULT2A1 substrate
0,161  0,011  Beta tubulin antagonist
0,170  0,020  Antineoplastic (uterine cancer)
0,170  0,020  Aldehyde dehydrogenase substrate
0,155  0,007  Bile acid receptor antagonist
0,175  0,026  Falcipain 3 inhibitor
0,167  0,019  AMP-activated protein kinase stimulant
0,193  0,045  Antiischemic, cerebral
0,175  0,027  Expectorant
0,152  0,004  GABA B receptor agonist
0,191  0,043  CNS active muscle relaxant
0,170  0,023  Interleukin 8 antagonist
0,191  0,045  Phobic disorders treatment
0,165  0,019  Breast cancer-resistant protein inhibitor
0,157  0,011  Postmenopausal disorders treatment
0,183  0,037  Cocaine dependence treatment
0,176  0,031  Cathepsin H inhibitor
0,205  0,060  Sigma receptor agonist
0,157  0,012  Paget's disease treatment
0,231  0,086  Myocardial infarction treatment
0,169  0,024  Antiprotozoal (Babesia)
0,218  0,075  Antineoplastic (glioblastoma multiforme)
0,163  0,020  Beta glucuronidase inhibitor
0,149  0,006  Estradiol 17 beta-dehydrogenase inhibitor
0,176  0,034  Movement disorders treatment
0,225  0,083  Neuropeptide Y2 antagonist
0,171  0,030  Antineoplastic antimetabolite
0,147  0,006  Narcotic antagonist
0,151  0,010  Vanilloid agonist
0,170  0,029  Growth stimulant
0,168  0,027  Nav1.1 sodium channel blocker
0,163  0,021  Antiviral (Papilloma)
0,158  0,018  Opioid delta receptor antagonist
0,208  0,069  Antiviral (Influenza)
0,168  0,029  Microtubule formation inhibitor
0,150  0,011  Lanosterol 14 alpha demethylase inhibitor
0,157  0,020  Urease inhibitor
0,159  0,023  Antiviral (Influenza B)
0,140  0,004  Sphingosine kinase inhibitor
0,155  0,020  Transcription factor STAT6 inhibitor
0,160  0,025  Sphingosine 1-phosphate receptor 4 antagonist
0,231  0,097  Antineoplastic (bladder cancer)
0,168  0,034  Antibacterial (Helicobacter pylori)
0,256  0,122  Antineoplastic (lung cancer)
0,175  0,041  Antianemic
0,140  0,007  Anticholelithogenic
0,140  0,007  D-Ala-D-Ala ligase inhibitor
0,141  0,008  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,212  0,080  Antiulcerative
0,175  0,043  Cell wall synthesis inhibitor
0,159  0,028  Contraceptive female
0,136  0,005  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,155  0,024  Adenylate kinase inhibitor
0,176  0,045  Cyclooxygenase 1 inhibitor
0,155  0,027  Antineoplastic, alkylator
0,159  0,031  5 Hydroxytryptamine 3A agonist
0,176  0,049  Anesthetic
0,143  0,016  Analgesic, opioid
0,150  0,024  NMDA receptor antagonist
0,164  0,039  Retinoprotector
0,139  0,015  Aminopeptidase I inhibitor
0,142  0,018  Inducible nitric-oxide synthase inhibitor
0,130  0,006  Endocannabinoid uptake inhibitor
0,210  0,087  Peptidyltransferase inhibitor
0,129  0,005  Heat shock protein 90 beta antagonist
0,146  0,023  Carcinogenic, group 2A
0,141  0,018  NMDA 2 receptor antagonist
0,136  0,014  Myeloperoxidase inhibitor
0,222  0,099  DNA damaging
0,195  0,073  Wound healing agent
0,136  0,015  Aromatase inhibitor
0,236  0,116  CYP2D6 inhibitor
0,163  0,044  Topoisomerase II inhibitor
0,216  0,097  Vascular (periferal) disease treatment
0,134  0,015  Phosphodiesterase 6D inhibitor
0,158  0,040  Adenylate cyclase inhibitor
0,231  0,113  Antineoplastic (colorectal cancer)
0,142  0,025  Topoisomerase II alpha inhibitor
0,129  0,013  Leukotriene antagonist
0,136  0,021  Opioid mu receptor antagonist
0,235  0,120  Antifungal
0,160  0,045  Anesthetic local
0,144  0,028  Multidrug resistance-associated protein 1 inhibitor
0,174  0,059  Neuropathy treatment
0,149  0,035  Papain-like protease (SARS coronavirus) inhibitor
0,218  0,104  Antiprotozoal (Trypanosoma)
0,124  0,011  Glycine receptor agonist
0,140  0,027  Nitric-oxide synthase inhibitor
0,134  0,021  Histamine N-methyltransferase inhibitor
0,127  0,015  Lipase inhibitor
0,156  0,044  Pregnane X receptor agonist
0,120  0,009  CC chemokine 5 receptor agonist
0,121  0,010  Beta adrenoreceptor antagonist
0,137  0,026  Acetylcholine release stimulant
0,138  0,027  Antiprotozoal (Toxoplasma)
0,125  0,015  Sphingosine 1-phosphate receptor 4 agonist
0,208  0,098  Aryl hydrocarbon receptor agonist
0,137  0,028  Uric acid excretion stimulant
0,112  0,004  Dopamine beta hydroxylase inhibitor
0,137  0,029  Electron transport complex I inhibitor
0,111  0,003  Sodium-dependent vitamin C transporter 2 inhibitor
0,156  0,048  Nav1.6 sodium channel blocker
0,113  0,005  MAP kinase kinase 7 inhibitor
0,165  0,057  Raynaud's phenomenon treatment
0,176  0,068  Antineoplastic (bone cancer)
0,112  0,005  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,116  0,008  Bombesin 3 receptor antagonist
0,143  0,036  Protein kinase C gamma inhibitor
0,121  0,014  TRPA1 antagonist
0,157  0,050  Antifungal (Cryptococcus)
0,127  0,020  Tocolytic
0,162  0,055  Hemostatic
0,121  0,015  Granulocyte macrophage colony stimulating factor agonist
0,110  0,004  Dihydroorotate oxidase inhibitor
0,151  0,046  Proteasome inhibitor
0,116  0,011  Beta 3 adrenoreceptor antagonist
0,119  0,014  Biliverdin reductase inhibitor
0,175  0,070  3C-like protease (Human coronavirus) inhibitor
0,203  0,099  Antineoplastic (cervical cancer)
0,206  0,102  Antineoplastic (liver cancer)
0,112  0,008  Antidote, organophosphates
0,112  0,008  Carbonic anhydrase XIV inhibitor
0,125  0,021  Glutamate dehydrogenase inhibitor
0,126  0,022  Ornithine decarboxylase inhibitor
0,216  0,112  Antineoplastic (colon cancer)
0,156  0,053  Nav1.2 sodium channel blocker
0,144  0,042  Gout treatment
0,125  0,022  Opioid kappa receptor antagonist
0,132  0,030  Catalase inhibitor
0,128  0,026  Thioredoxin inhibitor
0,113  0,013  Antidote, heavy metal
0,118  0,017  Leukotriene synthesis inhibitor
0,118  0,017  HIV-1 integrase (Strand Transfer) inhibitor
0,122  0,023  Restless leg syndrome treatment
0,135  0,036  Mediator release inhibitor
0,115  0,017  HIV-1 integrase inhibitor
0,105  0,007  Beta 2 adrenoreceptor antagonist
0,174  0,076  Antineoplastic (gastric cancer)
0,106  0,009  Leukotriene B4 antagonist
0,106  0,010  NMDA receptor subunit 3B antagonist
0,106  0,009  Beta 1 adrenoreceptor antagonist
0,110  0,013  Xanthine dehydrogenase inhibitor
0,130  0,034  Toll-Like receptor 4 antagonist
0,232  0,137  Angiogenesis inhibitor
0,156  0,060  Hearing loss treatment
0,106  0,012  Uterine relaxant
0,202  0,108  Antineoplastic (renal cancer)
0,114  0,021  NAT1 substrate
0,189  0,097  Antineoplastic enhancer
0,218  0,125  Antineoplastic (multiple myeloma)
0,114  0,022  Peroxisome proliferator-activated receptor gamma agonist
0,108  0,016  Aldose reductase inhibitor
0,128  0,037  Potassium channel (Ca-activated) activator
0,101  0,010  Glutamate (mGluR7) antagonist
0,190  0,099  Age-related macular degeneration treatment
0,110  0,020  Amidase inhibitor
0,100  0,011  Fatty acid synthase inhibitor
0,102  0,014  5 Hydroxytryptamine 2A agonist
0,116  0,027  Antifungal (Candida)
0,091  0,003  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,106  0,019  Carbamoyl phosphate synthetase inhibitor
0,121  0,034  Interleukin 1 beta converting enzyme inhibitor
0,119  0,032  Antifungal (Aspergillus)
0,104  0,018  Prostaglandin EP2 antagonist
0,090  0,004  Sphingosine kinase 1 inhibitor
0,095  0,009  Aconitate hydratase inhibitor
0,110  0,024  Nicotinic alpha4beta2 receptor antagonist
0,195  0,109  Antineoplastic (non-small cell lung cancer)
0,090  0,005  Beta 2 adrenoreceptor agonist
0,090  0,005  Adenylate cyclase 1 inhibitor
0,119  0,034  Androgen antagonist
0,109  0,024  Na+ K+ transporting ATPase inhibitor
0,093  0,009  NMDA receptor subunit 3A antagonist
0,124  0,040  Gastric antisecretory
0,214  0,130  Antiischemic
0,089  0,006  Liver X receptor alpha agonist
0,091  0,008  Postcoital contraceptive
0,166  0,084  Amyloid beta precursor protein antagonist
0,108  0,026  Purinergic P2X2 antagonist
0,224  0,142  Thyroid hormone antagonist
0,155  0,073  Diuretic
0,096  0,014  NMDA 2A receptor antagonist
0,131  0,050  Alcohol dehydrogenase substrate
0,086  0,004  Bombesin agonist
0,095  0,014  Antiviral (Parainfluenza)
0,085  0,005  Pregnane X receptor antagonist
0,140  0,060  Antiprotozoal (Trichomonas)
0,084  0,004  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,110  0,032  Interleukin 5 antagonist
0,113  0,035  Antiviral (Rhinovirus)
0,083  0,006  Nicotinic acid receptor agonist
0,084  0,006  Leukotriene C antagonist
0,082  0,005  Immunoglobulin Fc receptor antagonist
0,127  0,050  Endometrios treatment
0,107  0,031  Glutathione S-transferase inhibitor
0,127  0,051  Topoisomerase I inhibitor
0,094  0,018  NMDA 2C receptor antagonist
0,080  0,005  Glutamate (mGluR3) antagonist
0,132  0,057  Alkylator
0,220  0,145  Antiallergic
0,160  0,085  Death-associated protein kinase 2 inhibitor
0,101  0,027  CDC25A inhibitor
0,094  0,020  Argininosuccinate synthase inhibitor
0,260  0,187  Antiarthritic
0,082  0,009  Squalene epoxidase inhibitor
0,114  0,041  Electrolyte absorption antagonist
0,079  0,007  Purinergic P2X4 antagonist
0,092  0,020  Maillard reaction inhibitor
0,089  0,017  Antimycoplasmal
0,087  0,016  Opioid mu receptor agonist
0,075  0,004  Bombesin 3 receptor agonist
0,157  0,087  Antipruritic
0,075  0,005  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,144  0,074  Neuropeptide Y1 antagonist
0,074  0,004  ATP citrate lysase inhibitor
0,120  0,050  Antiviral (Poxvirus)
0,124  0,055  Shock treatment
0,087  0,019  NMDA 2B receptor antagonist
0,072  0,004  Sodium/glucose cotransporter 2 inhibitor
0,117  0,049  Antiinfertility, female
0,101  0,033  Cathepsin G inhibitor
0,080  0,012  Potassium channel Kv1.3 blocker
0,110  0,042  Glutamate (mGluR7) agonist
0,080  0,013  Epithelial sodium channel blocker
0,104  0,037  Glutamate release inhibitor
0,194  0,127  Antineoplastic (ovarian cancer)
0,161  0,094  Platelet adhesion inhibitor
0,077  0,010  Ryanodine receptor antagonist
0,082  0,015  Transcription factor RelA inhibitor
0,108  0,042  Protein kinase C zeta inhibitor
0,143  0,076  Thiol protease inhibitor
0,076  0,010  Glucose-6-phosphate isomerase inhibitor
0,085  0,020  Acyl-CoA dehydrogenase inhibitor
0,080  0,015  Calcium channel P-type blocker
0,076  0,012  Anesthetic inhalation
0,081  0,016  Sphingosine 1-phosphate receptor 3 antagonist
0,087  0,022  Protease 3C (Human rhinovirus) inhibitor
0,088  0,024  Peroxisome proliferator-activated receptor gamma antagonist
0,114  0,050  Anticataract
0,075  0,011  Vanilloid 2 antagonist
0,077  0,014  Topoisomerase II beta inhibitor
0,075  0,012  Lysophosphatidic acid 3 receptor antagonist
0,084  0,020  Glutamate (mGluR6) antagonist
0,094  0,032  Histone deacetylase stimulant
0,094  0,032  Histone deacetylase SIRT1 stimulant
0,119  0,056  Nav1.5 sodium channel blocker
0,076  0,014  Carbonic anhydrase VII inhibitor
0,067  0,005  Heme oxygenase inhibitor
0,066  0,004  Estrogen-related receptor beta antagonist
0,070  0,008  Dihydropteroate synthase inhibitor
0,121  0,059  Caspase 3 inhibitor
0,069  0,008  Geranyltranstransferase inhibitor
0,127  0,066  Nav1.3 sodium channel blocker
0,072  0,011  Mannosidase inhibitor
0,074  0,014  Glucose-6-phosphate translocase inhibitor
0,125  0,065  Histone deacetylase class III inhibitor
0,135  0,075  Histone deacetylase SIRT1 inhibitor
0,097  0,037  CYP2A6 inhibitor
0,083  0,025  Potassium channel (ATP-sensitive) blocker
0,064  0,007  Beta adrenoreceptor agonist
0,062  0,005  Free fatty acid receptor 1 antagonist
0,062  0,005  Cholesterol absorption inhibitor
0,182  0,125  Acute neurologic disorders treatment
0,081  0,024  Exportin-1 inhibitor
0,094  0,038  Glycine receptor antagonist
0,071  0,016  Alpha-mannosidase inhibitor
0,059  0,004  Thyroid hormone agonist
0,086  0,030  Antitreponemal
0,092  0,037  Interferon agonist
0,075  0,020  Peroxisome proliferator-activated receptor alpha agonist
0,059  0,004  Sodium/glucose cotransporter inhibitor
0,092  0,038  Caspase 7 inhibitor
0,079  0,025  Androgen agonist
0,059  0,005  Liver X receptor beta antagonist
0,081  0,027  CDC25B inhibitor
0,058  0,005  Liver X receptor alpha antagonist
0,111  0,057  HDL-cholesterol increasing
0,080  0,027  Aryl hydrocarbon receptor antagonist
0,094  0,041  Histamine H2 receptor antagonist
0,139  0,086  Acetylcholine M1 receptor antagonist
0,074  0,021  Opioid agonist
0,132  0,079  Antineoplastic (squamous cell carcinoma)
0,147  0,094  Muscular dystrophy treatment
0,075  0,023  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,077  0,025  Antihemophilic
0,060  0,008  Liver X receptor antagonist
0,121  0,069  DNA repair enzyme inhibitor
0,106  0,054  Folate antagonist
0,118  0,066  Constipation treatment
0,058  0,006  Leukotriene C4 antagonist
0,065  0,013  Oxytocin agonist
0,091  0,041  Somatostatin 1 agonist
0,059  0,010  Diamine oxidase inhibitor
0,202  0,152  Thyroid hormone beta antagonist
0,105  0,056  Dementia treatment
0,055  0,005  Leukotriene B4 receptor 1 antagonist
0,060  0,011  Alpha 1d adrenoreceptor agonist
0,060  0,012  Guanylate cyclase inhibitor
0,056  0,008  Glutamate (mGluR8) agonist
0,054  0,007  Uridine phosphorylase inhibitor
0,062  0,016  Cholesterol esterase inhibitor
0,055  0,009  Kainate receptor agonist
0,050  0,004  Estrogen-related receptor gamma antagonist
0,054  0,008  Catechol O-methyltransferase inhibitor
0,060  0,014  AICAR transformylase inhibitor
0,133  0,088  Cytidine deaminase inhibitor
0,056  0,011  Prostacyclin antagonist
0,068  0,023  Glucosylceramidase inhibitor
0,108  0,064  Nav1.4 sodium channel blocker
0,057  0,013  Dihydrofolate reductase inhibitor
0,137  0,093  Thrombolytic
0,074  0,030  MDM2 inhibitor
0,080  0,037  S-adenosyl-L-methionine decarboxylase inhibitor
0,080  0,036  Secretase beta inhibitor
0,055  0,012  Fumarate hydratase inhibitor
0,055  0,012  GABA uptake inhibitor
0,046  0,003  Vanilloid 2 agonist
0,115  0,072  Beta amyloid protein antagonist
0,133  0,090  Antiviral (Influenza A)
0,073  0,031  Interferon inducer
0,100  0,057  Vascular dementia treatment
0,046  0,004  Sodium/glucose cotransporter 1 inhibitor
0,069  0,027  Botulinum neurotoxin type A inhibitor
0,111  0,070  Mental retardation treatment
0,138  0,097  Aldose reductase substrate
0,050  0,009  Nucleoside transporters inhibitor
0,046  0,006  Glutamate (mGluR3) agonist
0,167  0,126  Antineoplastic (lymphoma)
0,043  0,003  Vesicular glutamate transport inhibitor
0,049  0,009  CF transmembrane conductance regulator antagonist
0,069  0,029  Cyclin D1 inhibitor
0,061  0,021  Heparanase inhibitor
0,048  0,008  GABA transporter 3 inhibitor
0,098  0,059  Fibroblast growth factor 1 antagonist
0,060  0,021  Adenosine deaminase inhibitor
0,086  0,047  Thioredoxin reductase inhibitor
0,081  0,042  HIV-1 reverse transcriptase inhibitor
0,060  0,021  CD45 antagonist
0,069  0,030  Histone deacetylase SIRT3 inhibitor
0,063  0,024  DNA helicase inhibitor
0,080  0,041  Phosphodiesterase VI inhibitor
0,049  0,010  Prostaglandin agonist
0,061  0,023  Prolyl endopeptidase inhibitor
0,124  0,086  Cytokine production inhibitor
0,182  0,144  Antineoplastic (pancreatic cancer)
0,057  0,020  Phosphate transporter inhibitor
0,042  0,005  Nicotinic acid receptor 2 antagonist
0,074  0,037  Gaucher disease treatment
0,075  0,038  Protein kinase C beta inhibitor
0,146  0,109  Sedative
0,115  0,078  Antiprotozoal (Amoeba)
0,085  0,048  Metalloproteinase-2 inhibitor
0,040  0,003  Estrogen-related receptor gamma agonist
0,065  0,029  Thromboxane antagonist
0,069  0,032  Acetylcholine M3 receptor antagonist
0,140  0,104  Antiviral (Hepatitis C)
0,127  0,091  Cyclooxygenase inhibitor
0,047  0,011  Liver X receptor beta agonist
0,073  0,038  Dopamine D1 antagonist
0,059  0,025  Bombesin 2 receptor antagonist
0,040  0,005  Prostaglandin F2 alpha agonist
0,039  0,005  Leukotriene B4 receptor 2 antagonist
0,056  0,023  Oleamide hydrolase inhibitor
0,107  0,073  Interleukin 1b antagonist
0,060  0,026  Nicotinic alpha3beta2 receptor antagonist
0,080  0,046  Sphingosine 1-phosphate receptor antagonist
0,049  0,016  Arginase inhibitor
0,037  0,004  Nicotinic acid receptor 1 antagonist
0,041  0,008  Prostaglandin EP2 agonist
0,078  0,045  Vanilloid 4 agonist
0,039  0,006  Prostaglandin EP4 agonist
0,058  0,026  Glycine transporter 2 inhibitor
0,065  0,033  Heme oxygenase stimulant
0,087  0,055  Phosphodiesterase IV inhibitor
0,051  0,019  HIV-1 protease inhibitor
0,037  0,006  Glutamate (mGluR1a) agonist
0,060  0,028  Thromboxane A2 antagonist
0,051  0,020  Glutamate (mGluR group III) antagonist
0,046  0,015  Phosphoglycerate kinase inhibitor
0,059  0,029  Thromboxane synthase inhibitor
0,045  0,015  Estrogen-related receptor alpha antagonist
0,045  0,015  Sirtuin 2 inhibitor
0,056  0,027  CXC chemokine 1 receptor antagonist
0,046  0,017  Aggrecanase 1 inhibitor
0,044  0,015  RNA-directed RNA polymerase inhibitor
0,037  0,008  CYP24 inhibitor
0,232  0,203  DNA directed DNA polymerase inhibitor
0,232  0,203  DNA polymerase beta inhibitor
0,041  0,013  Tryptophan 5 hydroxylase inhibitor
0,230  0,202  Antiparkinsonian
0,064  0,036  Carbonic anhydrase stimulant
0,073  0,046  Phospholipase D inhibitor
0,041  0,014  HCV NS5B polymerase inhibitor
0,061  0,034  Ribonucleoside-diphosphate reductase inhibitor
0,075  0,048  Metalloproteinase-9 inhibitor
0,062  0,035  Ribonucleotide reductase inhibitor
0,044  0,017  Opioid delta receptor agonist
0,081  0,054  Acetylcholine nicotinic antagonist
0,058  0,032  Adenine nucleotide translocase inhibitor
0,047  0,020  Urate transporter 1 inhibitor
0,108  0,081  Acetylcholine muscarinic antagonist
0,070  0,045  Neuronal nicotinic receptor antagonist
0,039  0,013  Lysophosphatidic acid 2 receptor antagonist
0,065  0,040  NMDA receptor agonist
0,034  0,009  Prostaglandin E2 agonist
0,066  0,042  Hyperparathyroidism treatment
0,048  0,024  Liver X receptor agonist
0,058  0,034  5 Hydroxytryptamine 7 agonist
0,066  0,043  Hypercalcemia treatment
0,100  0,076  Antihypermotility
0,031  0,008  Beta 1 adrenoreceptor agonist
0,090  0,066  ABCA1 expression enhancer
0,032  0,009  Hedgehog signaling activator
0,042  0,019  Nicotinic acid receptor 2 agonist
0,038  0,016  Melatonin receptor 1A agonist
0,093  0,071  Tourette's syndrome treatment
0,040  0,017  Peroxisome proliferator-activated receptor delta agonist
0,146  0,124  I kappa B kinase epsilon inhibitor
0,070  0,048  Prostaglandin-E synthase inhibitor
0,034  0,013  Lysine carboxypeptidase inhibitor
0,039  0,018  Ceramide glucosyltransferase inhibitor
0,030  0,009  Dopamine D1 agonist
0,063  0,042  NMDA receptor glycine site agonist
0,112  0,091  Antismoking
0,173  0,152  Streptokinase A inhibitor
0,042  0,021  Retinoid X receptor antagonist
0,092  0,072  Protease inhibitor
0,026  0,006  Neuraminidase (Influenza B) inhibitor
0,061  0,041  Alpha 2 adrenoreceptor agonist
0,109  0,090  Acetylcholinesterase inhibitor
0,038  0,019  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,045  0,027  Glutamate (mGluR4) antagonist
0,048  0,030  Thymidylate synthase inhibitor
0,044  0,025  Kainate receptor antagonist
0,044  0,026  Sphingosine 1-phosphate receptor 1 agonist
0,115  0,097  Interleukin 1 antagonist
0,043  0,025  Plasmepsin II inhibitor
0,039  0,021  Retinoid X alpha receptor agonist
0,106  0,088  Cholinergic antagonist
0,023  0,006  Thyroid hormone alpha antagonist
0,103  0,086  Myasthenia Gravis treatment
0,026  0,009  Isoleucine-tRNA ligase inhibitor
0,049  0,031  Aldosterone antagonist
0,053  0,036  Ornithine carbamoyltransferase inhibitor
0,130  0,113  MAP kinase kinase 4 inhibitor
0,031  0,015  Purinergic P2Y15 antagonist
0,063  0,046  Neuraminidase (influenza) inhibitor
0,049  0,032  Antibiotic Glycopeptide-like
0,040  0,023  Vanilloid 3 antagonist
0,023  0,006  Antibiotic Anthracycline-like
0,020  0,004  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,081  0,065  mTOR complex 2 inhibitor
0,103  0,088  Acetylcholine antagonist
0,049  0,034  Plasminogen activator inhibitor antagonist
0,051  0,036  Dihydroorotate dehydrogenase inhibitor
0,018  0,004  Thyroid hormone beta agonist
0,216  0,202  Atherosclerosis treatment
0,045  0,031  Fructose-1,6-bisphosphatase inhibitor
0,050  0,035  Factor III inhibitor
0,036  0,022  Calcitonin receptor agonist
0,070  0,056  Antibiotic
0,107  0,094  Antiacne
0,062  0,048  Neutrophil collagenase inhibitor
0,056  0,042  Dopamine uptake inhibitor
0,029  0,015  CXC chemokine 2 receptor antagonist
0,029  0,016  Leukotriene D4 antagonist
0,037  0,024  Kainate receptor 2 antagonist
0,048  0,036  Antiviral (Herpesvirus 3, Human)
0,028  0,015  Prostaglandin H2 antagonist
0,026  0,014  Glutamate (mGluR1) agonist
0,039  0,028  AMPA 4 receptor antagonist
0,034  0,023  Retinoid X alpha receptor antagonist
0,052  0,041  Lysine-specific demethylase 1A inhibitor
0,019  0,008  Thyroid hormone alpha agonist
0,029  0,018  1,3-Beta-glucan synthase inhibitor
0,061  0,051  Dopamine agonist
0,024  0,013  GRP78 expression inhibitor
0,022  0,012  Vesicular acetylcholine transporter inhibitor
0,015  0,005  Thromboxane agonist
0,017  0,008  Egl nine homolog 1 inhibitor
0,033  0,024  Peroxisome proliferator-activated receptor delta antagonist
0,019  0,009  Telomerase stimulant
0,106  0,097  Contraceptive
0,053  0,044  Sphingosine 1-phosphate receptor 1 antagonist
0,034  0,026  Retinoid X receptor agonist
0,015  0,006  Glutamate (mGluR6) agonist
0,039  0,031  Thymidine kinase inhibitor
0,026  0,018  Prostaglandin EP4 antagonist
0,061  0,053  Matrix metalloproteinase inhibitor
0,031  0,022  Cholesterol ester transfer protein antagonist
0,076  0,067  Calcium antagonist
0,038  0,030  Histone deacetylase 9 inhibitor
0,017  0,009  NMDA receptor phencyclidine site antagonist
0,026  0,018  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,042  0,034  Sphingosine 1-phosphate receptor agonist
0,041  0,033  Opioid kappa receptor agonist
0,036  0,028  5-Alpha-reductase inhibitor
0,085  0,078  MAP kinase kinase 1 inhibitor
0,022  0,014  Peroxisome proliferator-activated receptor alpha antagonist
0,041  0,034  Nicotinic receptor alpha3 subunit antagonist
0,100  0,093  Menstruation disorders treatment
0,035  0,027  Glutamate (mGluR8) antagonist
0,151  0,144  Platelet antagonist
0,018  0,011  G-protein-coupled receptor 120 agonist
0,032  0,026  Protein kinase (CK2) beta inhibitor
0,086  0,079  Posttraumatic stress disorder treatment
0,018  0,011  Alpha 2a adrenoreceptor agonist
0,016  0,010  Purinergic P2Y1 agonist
0,042  0,036  Phosphorylase inhibitor
0,056  0,050  Carbonic anhydrase inhibitor
0,010  0,005  Folate transporter 1 inhibitor
0,046  0,041  Carbonic anhydrase XII inhibitor
0,016  0,011  Thromboxane A2 agonist
0,025  0,020  Complement factor 1s inhibitor
0,031  0,026  Melatonin 2 agonist
0,020  0,015  Imidazoline I1 receptor antagonist
0,017  0,012  Ileal bile acid transport inhibitor
0,065  0,060  Phosphodiesterase 4D inhibitor
0,049  0,045  Nicotinic receptor alpha7 subunit antagonist
0,022  0,018  Fructose-1,6-bisphosphatase 1 inhibitor
0,062  0,058  Elastase 1 inhibitor
0,025  0,021  Thymidine phosphorylase inhibitor
0,034  0,031  Farnesoid X receptor agonist
0,137  0,133  MAP kinase kinase 2 inhibitor
0,039  0,036  Histamine H2 receptor agonist
0,080  0,077  Phosphodiesterase I inhibitor
0,064  0,061  Calcium channel L-type blocker
0,014  0,012  Calcium-sensing receptor antagonist
0,086  0,083  Antithrombocytopenic
0,020  0,018  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,011  0,009  Beta 3 adrenoreceptor agonist
0,018  0,016  Alpha 2b adrenoreceptor agonist
0,007  0,005  DNA topoisomerase III inhibitor
0,023  0,021  Lysophosphatidic acid receptor 1 agonist
0,041  0,039  Antimetabolite
0,021  0,019  Dopamine autoreceptor agonist
0,020  0,018  Lysophosphatidic acid 1 receptor antagonist
0,023  0,022  Sigma 2 receptor antagonist
0,179  0,178  Hepatic disorders treatment
0,035  0,034  Histone deacetylase 8 inhibitor
0,037  0,036  Carbonic anhydrase IV inhibitor
0,024  0,023  Acid ceramidase inhibitor
0,025  0,024  Baculoviral IAP repeat-containing protein 4 inhibitor
0,053  0,053  Neuraminidase inhibitor
0,027  0,026  Nicotinic alpha3beta4 receptor agonist
0,070  0,070  Chymotrypsin inhibitor
0,047  0,047  Carbonic anhydrase II inhibitor
0,036  0,035  5 Hydroxytryptamine 2B agonist
0,039  0,038  GABA B receptor antagonist
0,079  0,079  Aminoacyl-tRNA synthetase inhibitor

